Home Cart Sign in  
Chemical Structure| 305-84-0 Chemical Structure| 305-84-0
Chemical Structure| 305-84-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-carnosine is an antioxidant naturally found in skeletal muscle, brain tissue, and the heart, it can scavenge oxygen free radicals and transition metal ions, block protein-protein and protein-DNA cross-links induced by hypochlorite anions and toxic aldehydes, inhibit nonenzymatic protein glycation induced by aldose and ketose reducing sugars and inhibit the formation of toxic advanced glycation end products (AGE).

Synonyms: L-Carnosine; NSC 524045; β-Alanylhistidine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Chern, Hannah ; Caruso, Giuseppe ; Desaire, Heather ; Jarosova, Romana ;

Abstract: Alzheimer’s disease (AD), the leading cause of dementia, affects 1 in 9 people aged 65 and older. The disease impacts patients on multiple levels, from memory and problem-solving issues to difficulties with basic functions and personality changes. Unfortunately, there is only a handful of FDA-approved drugs, and none of them offer an effective cure. Therefore, recent strategies have focused on preventing and delaying disease onset, rather than curing already developed pathological changes in the brain. In this study, we investigated the therapeutic potential of carnosine (CAR), a naturally occurring dipeptide known for its multimodal mechanism of action, such as the ability to mitigate neuroinflammation, oxidative stress, and deficiencies in neurotropic factors, all of which are connected with aging-related cognitive decline and an increased risk of developing dementia. For this purpose, we utilized an okadaic acid-induced zebrafish model of AD, which replicates some of the key features of the disease, including hyperphosphorylation of tau protein, changes in Aβ-fragments, and cognitive decline. By employing a latent learning behavioral assay and fast-scan cyclic voltammetry, we evaluated the effect of CAR on the prevention of cognitive decline and neurochemical changes in the AD-like zebrafish brain. Our findings revealed that CAR prevents impaired learning and motor dysfunction in a sex-dependent manner and reduces anxiety-like behavior. Additionally, we found that CAR inhibits dopamine release impairment. Hence, our study demonstrates the potential of CAR as a promising candidate for further investigations focused on identifying molecules that could potentially serve as therapeutics for delaying the onset of AD.

Keywords: Alzheimer’s disease ; cognitive decline ; carnosine ; behavior ; dopamine ; electrochemistry ; zebrafish

Purchased from AmBeed:

Alternative Products

Product Details of Carnosine

CAS No. :305-84-0
Formula : C9H14N4O3
M.W : 226.23
SMILES Code : OC([C@@H](NC(CCN)=O)CC1=CN=CN1)=O
Synonyms :
L-Carnosine; NSC 524045; β-Alanylhistidine
MDL No. :MFCD00005207
InChI Key :CQOVPNPJLQNMDC-ZETCQYMHSA-N
Pubchem ID :439224

Safety of Carnosine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Carnosine

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 305-84-0 ]

[ 305-84-0 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1236199-60-2 ]
  • [ 305-84-0 ]
  • C28H41ClN8O5 [ No CAS ]
YieldReaction ConditionsOperation in experiment
In aq. buffer; at 37℃;pH 7.3; General procedure: <strong>[1236199-60-2]NL-101</strong> (0.03 g) was incubated with amino acids (0.02 g) and peptides (0.03 g) at 37 oC in a buffer solution, which pH was 5.3,7.3 and 9.3 respectively as the experimental surroundings. The pH of the samples was determined by a pH-meter (FE 20, MettlerToledo). All samples were kept at -20 oC until further analysis. The desalting step of the <strong>[1236199-60-2]NL-101</strong> adducts obtained under theexperimental conditions was not carried out before MS analysis.
 

Historical Records

Technical Information

Categories